ABNORMAL DRUG-METABOLISM IN CHRONIC-PANCREATITIS - TREATMENT WITH ANTIOXIDANTS

被引:41
作者
SANDILANDS, D
JEFFREY, IJM
HABOUBI, NY
MACLENNAN, IAM
BRAGANZA, JM
机构
[1] MANCHESTER ROYAL INFIRM,SCH MED,DEPT GASTROENTEROL,OXFORD RD,MANCHESTER M13 9WL,LANCS,ENGLAND
[2] MANCHESTER ROYAL INFIRM,SCH MED,DEPT SURG,MANCHESTER M13 9WL,LANCS,ENGLAND
[3] MANCHESTER ROYAL INFIRM,SCH MED,DEPT PATHOL,MANCHESTER M13 9WL,LANCS,ENGLAND
关键词
D O I
10.1016/0016-5085(90)90300-P
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Functional and morphological changes in hepatocytes, indicating induction of the drug metabolizing enzymes and free radical-mediated damage, were found in 4 patients with idiopathic chronic pancreatitis. The possibility that reflux of abnormal bile (rich in lipid peroxidation and other products generated through hepatic metabolism of xenobiotics) into the pancreatic duct may initiate pancreatic damage was negated when bile duct ligation and bile diversion did not abolish attacks of pancreatitis in 3 cases, although the evidence of reflux was indisputable in 1 of them who also had a pancreatoduodenectomy. Pancreatic acinar cells from that patient showed extensive microvesiculation, as did hepatocytes from each case. These observations suggest that pancreatic and liver damage in chronic pancreatitis proceed independently but by the same mechanism-heightened, but unmitigated, oxidative detoxification of xenobiotics by cytochromes P450. Therefore, although bile reflux is not a prerequisite, it could compound injury in the head of the gland. Antioxidants were prescribed to the 3 cases mentioned and, from the outset, to a fourth patient who showed the same liver changes. This unconventional approach has held attacks at bay during a follow-up period of 5 yr. © 1990.
引用
收藏
页码:766 / 772
页数:7
相关论文
共 34 条
[1]   FACTORS CONTRIBUTING TO THE ACCELERATED CLEARANCE OF THEOPHYLLINE AND ANTIPYRINE IN ADULTS WITH EXOCRINE PANCREATIC DISEASE [J].
ACHESON, DWK ;
HUNT, LP ;
ROSE, P ;
HOUSTON, JB ;
BRAGANZA, JM .
CLINICAL SCIENCE, 1989, 76 (04) :377-385
[2]  
Baron J, 1983, EXTRAHEPATIC DRUG ME, P73
[3]   CELLULAR PRODUCTION OF HYDROGEN-PEROXIDE [J].
BOVERIS, A ;
CHANCE, B ;
OSHINO, N .
BIOCHEMICAL JOURNAL, 1972, 128 (03) :617-&
[4]  
BRAGANZA JM, 1986, INT J PANCREATOL, V1, P9
[5]   RECALCITRANT PANCREATITIS - EVENTUAL CONTROL BY ANTIOXIDANTS [J].
BRAGANZA, JM ;
JEFFREY, IJM ;
FOSTER, J ;
MCCLOY, RF .
PANCREAS, 1987, 2 (04) :489-494
[6]  
BRAGANZA JM, 1988, INT J PANCREATOL, V3, P209
[7]  
BRAGANZA JM, 1982, GASTROENTEROLOGY, V82, P1341
[8]  
BRAGANZA JM, 1983, LANCET, V2, P375
[9]  
BRAGANZA JM, 1988, TRACE ELEM MED, V5, P78
[10]  
Braganza JM., 1996, RECENT ADV GASTROENT, V6, P251